Trial Profile
Effect of romiplostim given perioperative to patients with thrombocytopenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Apr 2015
Price :
$35
*
At a glance
- Drugs Romiplostim (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 21 Apr 2015 New trial record